Perioperative & Surgical Care

Stomas: ileostomy and colostomy management

Clinical Overview and When to Suspect Stoma Complications

— A stoma is a surgically created opening of bowel onto the abdominal wall for diversion of effluent

— Ileostomy: distal ileum; typically right lower quadrant (RLQ); spouted 2–3 cm to protect skin from corrosive small-bowel succus; output is liquid-to-paste, 500–1500 mL/day

— Colostomy: colon (most often sigmoid/descending in left lower quadrant or transverse); flush or minimally spouted; output more formed; 200–600 mL/day

— End stoma (single lumen, distal segment removed or oversewn — e.g., Hartmann's) vs loop stoma (two openings, proximal functional + distal mucous fistula; often temporary diversion)

— Colorectal cancer (low anterior or abdominoperineal resection)

— IBD, especially refractory ulcerative colitis (often end ileostomy after proctocolectomy; or temporary loop ileostomy protecting an ileal pouch-anal anastomosis)

— Diverticulitis with perforation (Hartmann procedure → end colostomy)

— Trauma, obstruction, fecal incontinence, radiation injury

— Any post-op patient with a stoma presenting with high output (>1.2–1.5 L/day in ileostomy), dehydration, AKI, electrolyte disturbances

— Dusky, black, or retracted stoma → ischemia

— No output for >12–24 h + distension/vomiting → obstruction or ileus

— Peristomal skin breakdown, leakage, or appliance failure

— Parastomal hernia bulge, especially with reducibility changes

Stoma fundamentals

Common indications

When to suspect a stoma problem on Step 3

Board pearl: The single most common cause of readmission after ileostomy creation is dehydration and AKI from high stoma output — Step 3 loves this. Counsel and follow proactively; thicken output and replete fluids before kidneys fail.

Key distinction: Ileostomy effluent is alkaline-poor, bicarbonate- and sodium-rich, liquid (skin-toxic, dehydrating); colostomy effluent is formed, less corrosive. Management priorities differ accordingly — fluid/electrolyte focus in ileostomy, regularity/odor/skin in colostomy.

Presentation Patterns and Key History

— Type of stoma (ileostomy vs colostomy; end vs loop), date created, indication, planned permanence

— Baseline output volume, consistency, and color; today's output vs baseline

— Last passage of flatus/stool through stoma; if loop with distal limb, last mucus from defunctioned segment

— Appliance type, change frequency, leakage history, peristomal skin issues

— Diet, fluid intake, oral rehydration solution use, medications (loperamide, PPIs, fiber thickeners)

— Early post-op (days 0–7): ileus → no output; ischemia → dusky stoma; mucocutaneous separation; bleeding

— Weeks 1–4: high-output ileostomy with dehydration, hypokalemia, hypomagnesemia, metabolic acidosis (bicarb loss), pre-renal AKI

— Months later: parastomal hernia, prolapse, retraction, stenosis, peristomal dermatitis, B12/iron deficiency (terminal ileum loss), gallstones, kidney stones (oxalate or uric acid in short-bowel physiology)

— Any time: obstruction from adhesions, food bolus (popcorn, nuts, mushrooms, raw vegetables), or hernia incarceration

— Crampy abdominal pain + emesis + decreased output → obstruction; bulge that no longer reduces → incarcerated parastomal hernia

— Lightheadedness, weight loss, oliguria + ileostomy → dehydration/AKI

— Burning, weeping peristomal skin → leakage and irritant contact dermatitis, not infection

Targeted stoma history — always ask

High-yield presentation patterns

Red-flag historical clues

Step 3 management: For a new ileostomy patient calling the clinic with output >1.5 L/day, instruct: hold osmotic agents, start oral rehydration solution (WHO-type, not plain water), add loperamide 4 mg QID before meals and bedtime, recheck electrolytes/creatinine within 24–48 h, and bring in if orthostatic or making <1 L urine/day.

Board pearl: Drinking large volumes of hypotonic free water paradoxically worsens ileostomy dehydration by increasing sodium loss — push isotonic ORS, not water or sports drinks.

Physical Exam Findings and Hemodynamic Assessment

— Vitals: tachycardia, orthostasis, hypotension, low urine output suggest volume depletion from high stoma output or third-spacing from obstruction

— Weight trend vs discharge weight; mucous membranes, skin turgor, capillary refill

— Mental status changes in elderly with electrolyte derangements (hypoNa, hypoK, hypoMg)

— Pink/red and moist = healthy, well-perfused mucosa

— Pale = anemia or poor perfusion

— Purple/dusky/black = ischemia — assess depth: superficial (above fascia, often observation) vs deep (below fascia, requires urgent re-exploration)

— Protrusion: spouted (ileostomy 2–3 cm), flush (colostomy), retracted (below skin → leakage), prolapsed (telescoped bowel >5 cm, edematous)

— Position: located in rectus muscle, away from bony prominences, skin folds, scars

— Erythema, erosion, ulceration → irritant dermatitis (most common), candidal (satellite lesions), pyoderma gangrenosum (purple undermined borders, often IBD)

— Cobblestoning, fistulae near stoma in Crohn disease

— Parastomal hernia: bulge with Valsalva, reducibility, overlying bowel sounds; tender + non-reducible + tachycardia → incarceration/strangulation

— Digital exam of stoma to assess for stenosis (should admit index finger) and proximal palpable mass

— Volume in 24-h appliance log; consistency (liquid vs porridge vs formed); blood, melena, undigested food

General and hemodynamic assessment

Stoma inspection — the "5 P's" approach

Peristomal skin and abdomen

Output characterization at bedside

CCS pearl: For a post-op day 5 patient with a dusky stoma, order bedside flexible stoma scope or insert a clear test tube + flashlight to assess viability depth — if ischemia extends below the fascia, page surgery for return to OR; if limited to mucosa above fascia, serial exam and let it slough.

Key distinction: Prolapse (excess length, viable mucosa) is usually urgent but not emergent; ischemic dusky stoma below fascia is a surgical emergency.

Diagnostic Workup — Initial Labs and Imaging

— BMP: assess Na, K, HCO₃ (often low — non-anion-gap metabolic acidosis from ileostomy bicarbonate loss), BUN/Cr (pre-renal pattern with BUN:Cr >20), glucose

— Magnesium and phosphorus: hypomagnesemia is common and underdiagnosed; perpetuates hypokalemia and refractory cramping

— CBC: anemia (chronic blood loss, B12/iron deficiency, IBD activity); leukocytosis with obstruction or peritonitis

— CRP, lactate: lactate elevation in ischemic bowel, strangulated hernia

— Urinalysis + urine Na/osmolality: concentrated urine, low urine Na in volume depletion; urine Na <20 mEq/L confirms hypovolemia

— B12, iron studies, folate: at baseline and annually in ileostomates (terminal ileum)

— Stool studies if indicated: C. difficile if antibiotic exposure; ova/parasites rarely; fecal calprotectin if IBD recurrence suspected

— Upright/supine abdominal radiograph (KUB): distension, air-fluid levels suggest obstruction; free air suggests perforation

— CT abdomen/pelvis with IV (± oral or water-soluble enteric) contrast: gold-standard for obstruction, parastomal hernia content, abscess, ischemia

— Water-soluble contrast study via stoma (stomagram/loopogram): evaluates distal limb of loop stoma before reversal, or identifies anastomotic leak/stricture

— Ultrasound of stoma site: bedside option for hernia or fluid collection in unstable patients

— Obtain in hypokalemic/hypomagnesemic patients: U waves, QT prolongation, risk of torsades

— Useful pre-op for stoma takedown planning

Initial laboratory evaluation

Imaging — first line

ECG

Step 3 management: A 65-year-old 3 weeks post ileostomy with cramps, weakness, and Cr 2.0 (baseline 0.9) — first orders: BMP, Mg, Phos, CBC, lactate, UA, IV NS bolus, hold ACEi/diuretics, loperamide, ORS, strict I/Os, daily weights.

Board pearl: Ileostomy patients classically develop hyperchloremic non-anion-gap metabolic acidosis with hypokalemia from intestinal HCO₃⁻ and K⁺ losses — mirrors diarrhea physiology.

Diagnostic Workup — Advanced and Confirmatory Studies

— CT with IV + water-soluble contrast administered via stoma: defines transition point in obstruction, leaks at anastomosis, mucocutaneous separation tracts

— MRI pelvis: best for evaluating perianal/pelvic recurrence of rectal cancer or IBD complications near a diverting stoma; assesses fistulae

— Endoscopy via stoma (ileoscopy or colonoscopy through stoma): evaluates recurrent Crohn disease at the neoterminal ileum (most common recurrence site after ileocolic resection), strictures, dysplasia surveillance, bleeding

— Contrast loopogram of the defunctioned distal limb before reversal: confirms anastomotic healing, rules out leak or stricture (e.g., before loop ileostomy takedown after LAR)

— Manometry/defecography: rarely, before reversal in patients with prior sphincter compromise to predict continence

— Schilling-equivalent metabolic labs: B12, methylmalonic acid, homocysteine in ileostomates >5 years; supplement parenterally if deficient

— 24-h urine studies in patients with kidney stones: low volume, low citrate, hyperoxaluria (enteric, in short bowel with intact colon), uric acid stones (acid urine from HCO₃ loss) — guides prevention

— DEXA: long-term ileostomates and patients on chronic steroids for IBD

— CEA: surveillance after colorectal cancer resection with permanent colostomy

— Distal contrast study to rule out leak/stricture

— Digital rectal exam and flexible sigmoidoscopy of anastomosis

— Nutritional optimization (albumin, prealbumin), smoking cessation, glycemic control

When initial workup is non-diagnostic, escalate

Specialized testing

Pre-reversal workup checklist (loop ileostomy after LAR)

CCS pearl: For a patient 3 months post-LAR with a diverting loop ileostomy awaiting reversal, order a water-soluble contrast enema (gastrografin) through the anus to evaluate the anastomosis — never reverse without imaging confirmation of intact anastomosis.

Key distinction: Mechanical obstruction (transition point on CT, dilated proximal bowel) requires NG decompression ± OR; post-op ileus (diffuse dilation, no transition point) is managed conservatively with bowel rest and electrolyte correction.

Risk Stratification and First-Line Management Logic

— Stable + mild dehydration + functioning stoma → outpatient management with ORS, loperamide, electrolyte recheck in 24–48 h

— AKI, electrolyte derangement, refractory high output, obstruction, ischemia, peritonitis → admit

— Peritonitis, strangulated hernia, deep stoma ischemia, free perforation → OR

— Define: output >1.2 L/day sustained, or any output causing dehydration/AKI

— Step 1: stop offending agents (prokinetics, magnesium-containing antacids, sorbitol-containing meds, excess hypotonic fluids)

— Step 2: isotonic ORS (e.g., WHO ORS, St. Mark's solution: 3.5 g NaCl + 2.5 g NaHCO₃ + 20 g glucose per liter); limit hypotonic fluids to <1 L/day

— Step 3: antimotility — loperamide 4 mg QID up to 16 mg/day (can go higher under specialist guidance), diphenoxylate-atropine, codeine if refractory

— Step 4: antisecretory — PPI (omeprazole 40 mg daily) to reduce gastric secretion volume

— Step 5: if refractory — octreotide 100 mcg SQ TID, or specialist referral for short-bowel syndrome with parenteral support

— Mucosal sloughing above fascia → observe; expect healing with possible later stenosis

— Ischemia below fascia (confirmed by scope or tube-and-light test) → urgent re-laparotomy

— Food bolus: stoma irrigation with warm saline via catheter, NPO, IVF; usually self-resolves

— Adhesive/hernia: NG tube, IVF, surgical consult; trial of water-soluble contrast may be both diagnostic and therapeutic

Triaging the stoma patient

High-output ileostomy management algorithm

Stoma ischemia triage

Obstruction at stoma

Step 3 management: For ileostomy output 2 L/day with Cr bump — admit, IV NS bolus then maintenance, hold ACEi/ARB/NSAIDs/diuretics, PPI + loperamide scheduled before meals, electrolyte repletion (Mg first to fix refractory K), nutrition and WOCN (wound/ostomy/continence nurse) consult.

Board pearl: Always replete magnesium before potassium in refractory hypokalemia — hypomagnesemia drives renal K⁺ wasting.

Pharmacotherapy — First-Line Drug Regimen

— Loperamide: 4 mg PO 30 min before meals and at bedtime (QID); titrate up to 16 mg/day standard, off-label up to 24 mg/day under supervision; does not cross BBB at therapeutic doses — preferred over opioids

— Diphenoxylate-atropine (Lomotil): 5 mg QID; second-line; mild opioid effect

— Codeine 30–60 mg QID or tincture of opium: for refractory cases; sedation and dependence concerns

— PPI: omeprazole 40 mg PO daily (or BID) reduces gastric acid/volume reaching the stoma; particularly helpful in first 6 months post-op when gastric hypersecretion peaks

— H2 blockers: alternative if PPI not tolerated

— Octreotide 100 mcg SQ TID (or long-acting): refractory high output, especially short-bowel syndrome; risks: gallstones, hyperglycemia, tachyphylaxis

— Soluble fiber (psyllium, methylcellulose) without extra water: thickens ileostomy output by absorbing fluid in the lumen

— Bananas, applesauce, rice, peanut butter, marshmallows as dietary thickeners

— Avoid insoluble fiber and gas-producing foods if patient symptomatic

— Oral magnesium oxide or glycinate for chronic hypomagnesemia; avoid magnesium citrate (osmotic laxative effect worsens output)

— Oral KCl for chronic hypokalemia

— Oral sodium bicarbonate for chronic non-AG acidosis in short-bowel patients

— Stoma stenosis: stool softeners (docusate), avoid fiber bulking

— Colostomy constipation: osmotic laxative (PEG 3350), adequate fluids

— Peristomal pyoderma gangrenosum: topical/intralesional steroids, topical tacrolimus; systemic immunosuppression for severe

Antimotility agents (cornerstone of high-output management)

Antisecretory agents

Bulking and fiber

Electrolyte and acid-base repletion

Adjuncts for specific stoma issues

Key distinction: Ileostomy patients need antimotility + antisecretory + soluble fiber to slow and thicken output; colostomy patients more often need osmotic laxatives and hydration to prevent constipation/obstruction.

Board pearl: Loperamide is preferred in ileostomates because it works locally on μ-receptors in the gut without CNS effects — high doses are safe and effective.

Procedural Management and Surgical Issues

— Pre-op stoma siting by enterostomal therapist: within rectus, visible to patient, away from belt line, scars, folds, bony prominences — poor siting predicts leakage and skin issues

— Ileostomy spouted via Brooke technique to direct effluent into appliance

— Loop stoma uses a rod for support, removed POD 5–7

— Stoma stenosis: dilation (digital or with Hegar dilators); surgical revision if severe

— Stoma prolapse: reduce manually with cold compress/sugar to reduce edema; surgical revision if recurrent, ischemic, or impairing function

— Parastomal hernia: elective repair if symptomatic — options include local repair, mesh repair (sublay/onlay), or stoma relocation; emergent repair for incarceration/strangulation

— Retraction with leakage: convex appliance + belt; surgical revision if persistent

— Mucocutaneous separation: pack with absorbable powder/dressing, allow secondary healing

— Typical timing: 8–12 weeks after creation for protective loop ileostomy after LAR (allow anastomotic healing); after Hartmann reversal, often 3–6 months

— Pre-op: confirm distal anastomotic integrity (contrast enema), nutritional and functional status optimized

— Post-takedown: monitor for ileus, leak at takedown site, low anterior resection syndrome (urgency, frequency, clustering)

— Remaining small bowel <200 cm with end jejunostomy/ileostomy → likely intestinal failure; needs parenteral nutrition, teduglutide (GLP-2 analog), possible transplant referral

Stoma creation principles (relevant to recognizing post-op complications)

Procedural interventions for complications

Stoma takedown (reversal)

Short bowel/IF considerations

CCS pearl: For incarcerated parastomal hernia with peritonitis: NPO, NG, IVF, broad-spectrum antibiotics (piperacillin-tazobactam), type and cross, consent for OR, surgical consult STAT — do not delay for prolonged imaging.

Board pearl: Parastomal hernia incidence approaches 50% within 2 years — many are asymptomatic and managed conservatively with support belts; repair only for obstruction, pain, leakage, or cosmesis.

Special Populations — Elderly and Renal/Hepatic Impairment

— Higher baseline risk of dehydration, AKI, falls from orthostasis with high-output ileostomy

— Diminished thirst response → push scheduled ORS rather than ad lib

— Polypharmacy: diuretics, ACEi/ARBs, NSAIDs, SGLT2 inhibitors all amplify volume depletion — hold or reduce during high-output episodes

— Cognitive and dexterity issues impair self-care; involve caregivers and home health/WOCN early

— Visual impairment and arthritis affect appliance changes — consider one-piece systems, pre-cut wafers

— Ileostomy + CKD is a high-risk combo: each high-output episode may cause progression

— Avoid nephrotoxins (NSAIDs, contrast when possible, aminoglycosides)

— Monitor potassium carefully — both hyperkalemia from CKD and hypokalemia from stoma losses possible

— Magnesium can accumulate in advanced CKD; oral repletion needs care

— Cirrhotics with stomas at risk for stomal varices (portosystemic shunting at mucocutaneous junction) → episodic massive bleeding; treat with local pressure, suture ligation, sclerotherapy, or TIPS — not banding, which traumatizes mucosa

— Encephalopathy risk amplified by dehydration and electrolyte shifts; lactulose dosing must balance against worsening stoma output

— Sodium and volume management is delicate — ORS provides needed sodium, but total volume must be monitored; daily weights essential

— Steroid use for IBD, altered nutrition, and ORS (contains glucose) can worsen glycemic control — adjust insulin

— SGLT2 inhibitors increase risk of dehydration and euglycemic DKA in high-output ileostomy — discontinue

Elderly stoma patients

Chronic kidney disease

Hepatic impairment

Heart failure

Diabetes

Step 3 management: For an 80-year-old on lisinopril, furosemide, and ibuprofen with new ileostomy and Cr rising — discontinue all three, start ORS, loperamide, recheck renal function in 48 h, and arrange home health for appliance training and weight monitoring.

Board pearl: Stomal variceal bleeding in a cirrhotic should prompt evaluation for portal hypertension and consideration of TIPS, the definitive treatment.

Special Populations — Pregnancy, Pediatrics, and Other Subgroups

— Generally well tolerated; expanding uterus may cause stoma prolapse, obstruction, or appliance fit issues

— Refit appliances every trimester; use flexible/convex wafers as abdomen changes

— Increased risk of dehydration in hyperemesis — low threshold for IV hydration

— Mode of delivery: vaginal delivery is preferred; stoma is not an indication for C-section unless obstetric reasons or prior complex pelvic surgery

— IBD patients: continue most maintenance therapies (biologics like infliximab, adalimumab generally continued; avoid methotrexate)

— Common indications: necrotizing enterocolitis, Hirschsprung disease, imperforate anus, IBD

— Higher relative fluid losses for body weight; strict I/Os and weight-based ORS

— Stoma growth with the child; frequent appliance resizing

— School and social adjustment counseling; involve child life and pediatric WOCN

— Body image, sexual function, and intimacy concerns dominate; UC patients post-IPAA often have a temporary loop ileostomy before pouch use

— Sexual function after APR/proctectomy: discuss retrograde ejaculation, dyspareunia, fertility (oocyte/sperm banking before pelvic radiation)

— Hernia belts/stoma guards during contact sports; gradual return to lifting at 6–8 weeks post-op

— Hydration strategy with ORS, not water alone, during exercise

— Prayer hygiene (Islam): provide guidance on appliance changes around prayer times

— Dietary practices (kosher, halal, vegetarian): tailor nutritional counseling to maintain adequate sodium and protein

Pregnancy with a stoma

Pediatric stomas

Adolescents and young adults

Athletes and active patients

Cultural/religious considerations

Key distinction: In pregnant ileostomates, rising output and dehydration can mimic hyperemesis — always check electrolytes and consider stoma-specific causes before attributing solely to pregnancy.

Board pearl: Vaginal delivery is not contraindicated by a stoma; C-section is reserved for obstetric or pelvic-surgical indications.

Complications and Adverse Outcomes

— Stoma ischemia/necrosis: technical (tension, devascularization), shock; assess depth, OR if below fascia

— Mucocutaneous separation: gap between stoma and skin; pack and heal by secondary intent

— Bleeding: usually mucosal trauma from appliance; rule out coagulopathy, varices

— Retraction: stoma below skin level; convex appliances; surgical revision if severe

— Obstruction: ileus, edema, food bolus, adhesions

— High-output dehydration: leading readmission cause for new ileostomy

— Parastomal hernia: up to 50% by 2 years; risk factors include obesity, COPD, malnutrition

— Prolapse: more common with loop transverse colostomies

— Stenosis: from chronic ischemia or recurrent dermatitis; managed with dilation or revision

— Peristomal skin disease: irritant dermatitis (most common), allergic dermatitis, candidiasis, folliculitis, pyoderma gangrenosum (think IBD)

— Stomal varices: in portal hypertension

— B12 deficiency: terminal ileal loss → check annually, supplement parenterally

— Fat-soluble vitamin deficiency (A, D, E, K) in extensive small-bowel loss

— Cholelithiasis: bile salt depletion → cholesterol stones

— Nephrolithiasis: uric acid stones (acidic, concentrated urine) in ileostomates; calcium oxalate stones in colectomized patients with intact colon + small-bowel disease (enteric hyperoxaluria — colon absorbs unbound oxalate)

— Depression, anxiety, body image disturbance, social isolation, sexual dysfunction

— Significant impact on quality of life; structured WOCN follow-up improves outcomes

Early complications (days to weeks)

Late complications (months to years)

Metabolic and nutritional

Psychosocial

CCS pearl: A patient 2 years post-end ileostomy with flank pain and hematuria — non-contrast CT KUB likely shows uric acid stone; manage with hydration, urinary alkalinization with potassium citrate, and dietary modification.

Key distinction: Ileostomy → uric acid stones; ileal resection with intact colon → calcium oxalate stones (enteric hyperoxaluria).

When to Escalate Care — ICU, Consult, and Inpatient Triage

— Dusky stoma with ischemia extending below the fascia (scope/tube test)

— Incarcerated or strangulated parastomal hernia

— Free perforation, peritonitis, sepsis with abdominal source

— Massive stomal bleeding not controlled with local pressure (suspect varices)

— Complete bowel obstruction failing conservative management at 48–72 h

— Stoma output >1.5–2 L/day with AKI or electrolyte derangement

— Symptomatic dehydration, orthostasis, inability to maintain oral intake

— Partial obstruction needing NG decompression, IVF, and serial exams

— Significant peristomal infection, abscess requiring drainage

— New diagnosis of complication needing diagnostic workup (e.g., recurrent IBD, anastomotic stricture)

— Septic shock from intra-abdominal source

— Severe electrolyte derangement with hemodynamic or arrhythmic compromise (e.g., K <2.5 with U waves)

— Massive GI bleed requiring resuscitation

— Post-operative respiratory failure or vasopressor need

— Colorectal surgery: any structural stoma issue, hernia, ischemia, takedown planning

— Gastroenterology: recurrent IBD, neoterminal ileum endoscopy, surveillance

— WOCN (wound, ostomy, continence nurse): every admission and outpatient encounter — single highest-impact consult

— Nutrition: short bowel, weight loss, TPN consideration

— Nephrology: recurrent AKI, kidney stones, electrolyte management

— Psychiatry/social work: adjustment, depression, support groups (United Ostomy Associations)

— Avoid same-day discharge after admission for high-output ileostomy — document 24 h of stable outputs, oral intake, and labs before sending home

Immediate surgical consultation and likely OR

Admit to hospital (floor)

ICU triage

Specialty consults

Transitions of care

Step 3 management: New ileostomy readmission with Cr 2.5, K 2.8, output 2.5 L/day — admit to floor, IV NS + KCl, hold home antihypertensives and diuretics, scheduled loperamide + PPI, WOCN consult, ORS teaching, surgical follow-up before discharge.

CCS pearl: Always re-consult WOCN before discharge — single best lever to prevent bounce-back.

Key Differentials — Within Stoma-Related Causes

— Diffuse bowel dilation on imaging, no transition point

— Typical first week post-op; gradual resolution

— Management: NPO, IVF, ambulation, correct electrolytes, minimize opioids, alvimopan in select patients

— Food bolus: undigested fibrous food at stoma; treat with stoma irrigation

— Adhesions: most common late mechanical cause; NG decompression, water-soluble contrast challenge

— Internal hernia: post-laparoscopic mesenteric defects

— Stoma stenosis: narrowed fascial or skin opening, palpated on digital exam

— Tender, non-reducible bulge; obstructive symptoms; strangulation if signs of ischemia or peritonitis

— Mucosa pulls below skin → poor appliance seal, leakage, dermatitis

— May mimic obstruction by causing twisting

— Dusky color; output ceases; depth determines management

— Crohn disease at neoterminal ileum (stricturing, obstructive symptoms)

— Anastomotic recurrence of colorectal cancer

— Radiation enteritis with stricturing in patients with prior pelvic radiation

— Partial obstruction proximal to stoma can paradoxically present with high liquid output (decompressive diarrhea around impaction)

— Recurrent Crohn disease, C. difficile colitis (yes, can occur in colostomies/ileostomies — check stool for toxin)

— Medication-induced (prokinetics, sorbitol, magnesium, recent antibiotic with bile salt malabsorption)

Patient presents with decreased stoma output and abdominal pain — differential within "stoma category":

Post-operative ileus

Mechanical obstruction

Parastomal hernia with incarceration

Stoma retraction

Stoma necrosis/ischemia

Recurrent disease

High-output ileostomy with hidden cause

Key distinction: C. difficile infection in ileostomates is underrecognized — toxin testing of ileostomy effluent is valid; treat with oral vancomycin or fidaxomicin.

Board pearl: Sudden change from formed to liquid stoma output is not always "diarrhea" — consider partial obstruction with overflow.

Key Differentials — Other Etiologic Categories

— C. difficile colitis (still possible in patients with retained colon segments or ileostomies)

— Bacterial overgrowth in dilated/blind loops or short bowel — bloating, malabsorption; diagnose with breath testing or empiric trial of rifaximin

— Viral gastroenteritis affecting stoma output transiently

— Intra-abdominal abscess (post-op leak, diverticular)

— Crohn disease recurrence at neoterminal ileum (most common site after ileocolic resection)

— Pouchitis in patients with IPAA and diverting ileostomy (inflammation of the J-pouch)

— Radiation enteritis in patients with pelvic XRT history

— Recurrent colorectal cancer at anastomosis or peritoneum

— Carcinoid tumor in small bowel — flushing, diarrhea/high output, right heart valve disease (5-HIAA testing)

— Lymphoma in IBD patients on long-term thiopurines

— Hyperthyroidism → increased motility and high output

— Adrenal insufficiency in patients on chronic steroids who abruptly taper — hyponatremia, hyperkalemia, hypotension

— Diabetes-related autonomic dysmotility

— Antibiotics (loss of gut flora, bile acid malabsorption)

— Magnesium-containing antacids, PPIs (paradoxically can worsen output if SIBO develops), sorbitol-containing elixirs, metformin, SGLT2 inhibitors, chemotherapy

— Tube feeds with high osmolarity

— Mesenteric ischemia (post-prandial pain, weight loss, food fear) in vasculopaths

— Portal/mesenteric venous thrombosis

— Anxiety, eating disorders with laxative misuse

— Adjustment disorder amplifying somatic complaints

Beyond stoma mechanics — broader differential for the stoma patient with new symptoms:

Infectious

Inflammatory

Neoplastic

Endocrine/metabolic

Medication-induced

Vascular

Psychogenic/functional

Step 3 management: Stoma patient with new diarrhea after a hospitalization → send C. diff PCR/toxin from stoma effluent, review recent antibiotic exposure, and start empiric oral vancomycin if pretest probability is high.

Key distinction: Always reconcile medication and recent procedure history before attributing high output to "just the stoma."

Secondary Prevention, Discharge Plan, and Long-Term Management

— Written and demonstrated appliance care plan — patient performs at least one independent change before discharge

— WOCN follow-up scheduled within 1–2 weeks

— Surgical follow-up at 2–4 weeks

— Output diary with thresholds for action: call clinic if output >1.2 L/day or <200 mL/day, weight change >2 lb in 2 days, signs of dehydration

— ORS prescription/recipe and how to use it; loperamide 4 mg QID PRN with scheduled dosing if needed

— PPI continuation × 6 months for new ileostomy (high-output prevention)

— Avoid: NSAIDs (AKI, ulcers), magnesium-containing laxatives, sorbitol elixirs, SGLT2 inhibitors (dehydration/DKA risk)

— Adjust: diuretics, ACEi/ARB doses based on volume status

— DVT prophylaxis as indicated; resume home anticoagulation per surgical plan

— B12 annually in ileostomates; supplement if low (parenteral preferred)

— Iron studies, vitamin D, magnesium periodically

— Bone density every 1–2 years if at risk

— Colorectal cancer surveillance per indication (e.g., colonoscopy via stoma in CRC patients per ACS/USMSTF schedule: 1 year post-op, then 3 years, then every 5 years if normal)

— IBD surveillance for dysplasia in retained bowel

— Diet: chew thoroughly, hydrate with ORS, avoid known obstructive foods initially (popcorn, nuts, mushrooms, raw veg, citrus pith)

— Exercise: progressive return at 6–8 weeks; stoma guard for contact sports

— Travel: spare supplies, "ostomy travel card," hydration strategy

— Sexual health and intimacy counseling; support groups

Discharge bundle for new ileostomy/colostomy

Medications to review at discharge

Long-term surveillance

Lifestyle and counseling

Board pearl: Schedule early WOCN visit within 1–2 weeks and labs at 1–2 weeks post-discharge — proven to reduce readmissions for dehydration.

Key distinction: Discharge readiness is not "patient is afebrile and tolerating diet" alone — it requires demonstrated appliance competency, output stability, and a follow-up safety net.

Follow-Up, Monitoring, and Rehabilitation

— 2 weeks: WOCN + surgery — wound check, appliance fit, output review, BMP/Mg

— 4–6 weeks: surgery follow-up for clearance to lift/exercise; reassess for parastomal hernia

— 3 months: re-evaluate for stoma takedown if temporary; pre-op contrast study

— 6 months and annually: nutritional labs (B12, iron, vitamin D, magnesium), weight, kidney function

— Cancer surveillance per oncology schedule

— Daily output volume and consistency

— Daily weight (especially first month)

— Urine output and color (pale yellow = adequate hydration)

— Symptoms: lightheadedness, cramps, palpitations, decreased urination → seek care

— Stoma color, size, peristomal skin appearance

— Physical therapy if deconditioned, particularly elderly

— Gradual reintroduction of foods; food diary to identify triggers

— Pelvic floor PT for low anterior resection syndrome after stoma reversal

— Return to work timeline: typically 4–8 weeks depending on occupation

— How to thicken output (soluble fiber, marshmallows, bananas, applesauce)

— How to recognize and respond to dehydration

— Sick-day rules: hold ACEi/ARB/diuretics/SGLT2i, increase ORS, contact clinic

— Skin care: barrier products, appropriate appliance sizing (template), avoid harsh soaps

— When to call: high output, no output, fever, severe pain, dusky stoma, bleeding, parastomal bulge change

— Screen for depression at each visit (PHQ-9)

— Refer to support groups (United Ostomy Associations of America)

— Sexual health discussions — often patient-initiated only if clinician opens the door

Visit cadence

Self-monitoring parameters

Rehabilitation and functional recovery

Patient education priorities

Psychosocial

CCS pearl: At each follow-up, review the output diary and recheck Cr, K, Mg, HCO₃ for new ileostomates — this is the highest-yield, lowest-effort longitudinal intervention.

Board pearl: Sick-day rules — if vomiting or febrile, the ileostomate must double ORS intake and hold nephrotoxins to prevent AKI.

Ethical, Legal, and Patient Safety Considerations

— Pre-op discussion must include: permanence vs reversibility, expected output, body image, sexual function, fertility implications (pelvic surgery), risk of complications (hernia, leakage), lifestyle adjustments

— Pre-op WOCN siting is a documented standard of care — failure to site appropriately and document is a recognized malpractice issue

— In emergency surgery (perforation, obstruction) where pre-op siting is impossible, document the rationale; involve WOCN post-op as soon as feasible

— Patients with capacity may refuse stoma even when life-saving; document discussion, alternatives, and second opinion offer

— Surrogate decision-making per state hierarchy when patient lacks capacity

— Advance directives may address surgical interventions in patients with chronic illness (e.g., advanced cancer with obstruction — palliative diversion vs comfort care)

— Highest-risk handoff in this topic: discharge home with a new ileostomy. Up to 20% readmission rate, most for dehydration/AKI

— Mitigation: teach-back education, written instructions in patient's language and literacy level, scheduled follow-up phone call within 48–72 h, early WOCN and surgery visits, lab check at 1–2 weeks

— Medication reconciliation: ensure SGLT2i, NSAIDs, ACEi/ARB doses are addressed; avoid prescribing osmotic laxatives by mistake in ileostomy patients

— Ostomy supplies are expensive; Medicare/Medicaid coverage varies; document medical necessity to ensure supply access

— Address health literacy, language barriers (interpreter for teaching), and home-care availability

— Standardize stoma assessment and output documentation on every shift

— Avoid PO osmotic agents and bowel prep in ileostomates without surgical guidance

— Skin injury from poor-fitting appliance is a reportable hospital-acquired condition in many systems

Informed consent for stoma creation

Decision-making capacity and autonomy

Transitions-of-care safety

Equity and access

Patient safety in the hospital

Step 3 management: Before discharging a new ileostomate, perform teach-back: patient must verbalize how to mix ORS, when to call, and demonstrate one appliance change. Document this explicitly — it is both a safety and medico-legal safeguard.

Board pearl: Failure to obtain pre-op stoma siting when feasible is a recognized standard-of-care lapse.

High-Yield Associations and Rapid-Fire Clinical Facts

— Ileostomy → hyperchloremic non-AG metabolic acidosis + hypokalemia + hypomagnesemia

— Ileostomy → uric acid kidney stones (acidic, concentrated urine)

— Ileal resection + intact colon → calcium oxalate stones (enteric hyperoxaluria)

— Terminal ileum loss → B12 deficiency + bile salt malabsorption + gallstones (cholesterol)

— Loop ileostomy post-LAR → reverse at 8–12 weeks after distal contrast study

— Hartmann reversal → typically 3–6 months after initial operation

— Parastomal hernia incidence ~50% at 2 years

— Pyoderma gangrenosum around stoma → think IBD, treat with topical/systemic immunosuppression, NOT debridement (pathergy)

— Stomal varices → cirrhosis with portal hypertension → treat with TIPS

— Dusky stoma below fascia → OR; above fascia → observe

— Recurrent Crohn after ileocolic resection → neoterminal ileum; scope via stoma

— Loperamide: no CNS effect at standard doses — preferred antimotility

— PPI 40 mg daily: reduces stoma output ~30%

— Octreotide: refractory; watch for gallstones and hyperglycemia

— Hold SGLT2 inhibitors in high-output states — euglycemic DKA and AKI risk

— Magnesium oxide/glycinate preferred for oral repletion; avoid magnesium citrate (osmotic laxative)

— Stoma effluent can be sent for C. difficile toxin testing

— Loopogram before reversal is mandatory

— B12 annually in ileostomates

— Bedside flashlight + clear tube assesses stoma viability depth at the bedside

— WOCN follow-up within 1–2 weeks

— Output diary + scheduled labs

— ORS, scheduled loperamide, PPI for 6 months in new ileostomy

— Teach-back education

Rapid associations

Drug pearls

Diagnostic pearls

Best discharge interventions

Board pearl: The "three numbers to know" for any new ileostomate: target output <1.2 L/day, ORS sodium ≥90 mEq/L, loperamide up to 16 mg/day standard.

Board Question Stem Patterns

— Vignette: 60-year-old man 3 weeks post-proctocolectomy for UC presents with fatigue, cramps, Cr 2.0 (baseline 0.9), K 3.0, HCO₃ 18, output 2 L/day. Has been drinking "lots of water."

— Best next step: isotonic ORS, loperamide, hold ACEi/diuretics, IV NS bolus, electrolyte repletion

— Distractor: "increase free water intake" — wrong; worsens losses

— Vignette: stoma is purple-black; tube-and-light shows ischemia extending 3 cm below fascia

— Best next step: return to OR

— Distractor: observation, topical care — only appropriate if limited to mucosa above fascia

— Vignette: irreducible tender bulge, vomiting, no output, tachycardia, lactate 3

— Best next step: IVF, NG, antibiotics, surgical consult for emergent repair

— Vignette: flank pain, hematuria, stoma 5 years

— Stone type: uric acid; management: hydration, potassium citrate to alkalinize urine

— Diagnosis: pyoderma gangrenosum

— Best treatment: topical/intralesional steroids or tacrolimus, systemic immunosuppression; avoid debridement (pathergy)

— Diagnosis: C. difficile of retained colon or via stoma

— Treatment: oral vancomycin or fidaxomicin

— Vignette: loop ileostomy post-LAR, scheduled for takedown

— Best next step: water-soluble contrast enema to assess anastomosis

— Diagnosis: stomal varices

— Definitive treatment: TIPS

— Mode of delivery: vaginal preferred

— Action: discontinue SGLT2i to prevent euglycemic DKA and AKI

Stem pattern 1 — High-output ileostomy with AKI

Stem pattern 2 — Dusky stoma POD 2

Stem pattern 3 — Parastomal bulge with obstruction

Stem pattern 4 — Kidney stone in long-term ileostomate

Stem pattern 5 — Purple ulcerated peristomal skin in UC patient

Stem pattern 6 — Recurrent diarrhea-like high output after antibiotics

Stem pattern 7 — Pre-reversal evaluation

Stem pattern 8 — Stomal hemorrhage in cirrhotic

Stem pattern 9 — Pregnancy with stoma

Stem pattern 10 — SGLT2i and ileostomy

Board pearl: When the stem mentions "drinking plenty of water" + ileostomy + AKI, the answer is almost always isotonic ORS + antimotility, not more water.

One-Line Recap

— Ileostomy physiology: liquid, alkaline-poor, Na/HCO₃-rich effluent → hyperchloremic non-AG metabolic acidosis, hypokalemia, hypomagnesemia, uric acid kidney stones, and B12 deficiency from terminal ileum loss

— High-output algorithm: stop nephrotoxins and osmotic agents → isotonic ORS (not free water) → loperamide 4 mg QID → PPI 40 mg daily → soluble fiber → octreotide if refractory; replete Mg before K; hold SGLT2i, ACEi/ARB, NSAIDs, diuretics in acute high output

— Surgical red flags: dusky stoma below fascia, incarcerated parastomal hernia, peritonitis, massive bleeding (think stomal varices → TIPS) → OR or emergent intervention; parastomal hernia ~50% at 2 years but elective repair only if symptomatic

— Discharge and follow-up bundle: pre-op WOCN siting, demonstrated appliance competency with teach-back, output diary, ORS prescription, scheduled loperamide and PPI for 6 months in new ileostomy, WOCN visit within 1–2 weeks, labs (BMP, Mg) at 1–2 weeks, B12 annually, pre-reversal contrast study at 8–12 weeks for loop ileostomy after LAR; vaginal delivery acceptable in pregnancy

One-liner: Stomas demand proactive output management, electrolyte and skin vigilance, and structured longitudinal follow-up — with ileostomies driving dehydration/AKI through sodium and bicarbonate losses, colostomies more often facing constipation and obstruction, and both requiring early WOCN involvement, teach-back education, and clear escalation criteria to prevent readmission and complications.

Top high-yield recap bullets

Board pearl: The single greatest preventable adverse event in stoma care is readmission for dehydration/AKI in the new ileostomate — pre-empt it with ORS education, scheduled antimotility, early WOCN and lab follow-up, and explicit sick-day rules to hold nephrotoxic medications.